Cargando…

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma

BACKGROUND: Early diagnosis for α-fetoprotein (AFP) negative hepatocellular carcinoma (HCC) remains a critical problem. Metabolomics is prevalently involved in the identification of novel biomarkers. This study aims to identify new and effective markers for AFP negative HCC. METHODS: In total, 147 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zuyuan, Li, Huigang, He, Chiyu, Yang, Modan, Chen, Hao, Yang, Xinyu, Zhuo, Jianyong, Shen, Wei, Hu, Zhihang, Pan, Linhui, Wei, Xuyong, Lu, Di, Zheng, Shusen, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947281/ https://www.ncbi.nlm.nih.gov/pubmed/36845695 http://dx.doi.org/10.3389/fonc.2023.1072775

Ejemplares similares

One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma
por: Chen, Hao, et al.
Publicado: (2022)

Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury
por: He, Chiyu, et al.
Publicado: (2022)

Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer
por: Lu, Di, et al.
Publicado: (2022)

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020)

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation
por: Yang, Xinyu, et al.
Publicado: (2021)

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
por: Wang, Ting, et al.
Publicado: (2020)

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
por: Yang, Xinyu, et al.
Publicado: (2020)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)

TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma
por: Mao, Liping, et al.
Publicado: (2017)

A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma
por: Luo, Chang-Liang, et al.
Publicado: (2019)

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
por: Wang, Jingrui, et al.
Publicado: (2023)

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma
por: Lu, Liang-He, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments
por: Sun, Yu, et al.
Publicado: (2023)

Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study
por: Shen, Xiaoyong, et al.
Publicado: (2020)

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma
por: Zhang, Xuanyu, et al.
Publicado: (2019)

Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma
por: Vongsuvanh, Roslyn, et al.
Publicado: (2016)

Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma
por: Pan, Binhua, et al.
Publicado: (2021)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
por: Sun, Jianping, et al.
Publicado: (2019)

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhuang, Runzhou, et al.
Publicado: (2017)

Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
por: Wang, Xueying, et al.
Publicado: (2020)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
por: Xu, Fei, et al.
Publicado: (2021)

The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study
por: Wang, Qi, et al.
Publicado: (2021)

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
por: Liu, Ruoyu, et al.
Publicado: (2021)

Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations
por: Zhao, Ting, et al.
Publicado: (2020)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Prognostic value of des-γ-carboxyprothrombin in patients with AFP-negative HCC treated with TACE
por: Sun, Hanyao, et al.
Publicado: (2022)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
por: Feng, Honglei, et al.
Publicado: (2021)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
por: Brusset, Bleuenn, et al.
Publicado: (2021)

AFP
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_43vccak6342lst4o35cn2rs2js